ABSTRACT
‫د‬

INTRODUCTION
reast cancer is the most common cancer in women worldwide and the second leading cause of cancer death among females after lung cancer, [1] accounting for 23% of total cancer cases and 14% of cancer. [2] There is a wide variation in the incidence and mortality rate of breast cancer among populations, being highest in developed countries and lowest in developing countries.
[3]
This difference could be due the differences in the life style and reproductive habits or due to improved screening and diagnostic tools of breast cancer in developed countries. Breast cancer is the most common cancer among women in Arabic countries with a median age at presentation is around 50 years. There are increased percentage of younger-age group women with breast cancer which is associated with aggressive biological characters. Some breast cancers have hormone receptors such as estrogen and/or progesterone receptors (ER & PR). Tumor with hormone positive receptors has better prognosis than that with hormone negative receptors. [8] Some breast cancers have over-expression of Human Epidermal growth factor. Receptor 2(HER2) which is a product of an oncogene that helps cells to grow, divide and repair themselves. It is amplified and over-expressed in 20-30% of breast cancer. Breast cancer with HER2 over-expression tends to have more aggressive course, higher risk of recurrence and poor prognosis.
[9] ER and PR status has been used for many years to determine a patient's suitability for endocrine therapy. More recently, testing for HER2 has been included in routine patient work-up, with recognition of its value both as a prognostic marker and, more particularly, in predicting response to trastuzumab (Herceptin).
[10] The most widely B used breast cancer grading system is the modified Nottingham Grading System (NGS) of Scarff-Bloom Richardsom (SBR) system which depends on nuclear pleomorphism, tubular formation and mitotic rate.
[11] A newer proposed semi-automated method for breast cancer grading (N+P) system used nuclear pleomorphism and proliferative index measured by immunohistochemistry.
[12] Prognosis of breast cancer depends on many factors including age, histological type, histological grade and stage, hormone status and gene influence. [13] Aim of the study, is to evaluate the expression of hormone receptors status (estrogen and progesterone) and HER2 over-expression in breast cancer cases in our locality and to compare them with patien. t's age, histological grade, and stage of tumor. Total score = proportion score + intensity score Note: Total score for ER and PR more than 3 is considered as positive for ER and PR. Table 2 . IHC scoring system of HER2.
MATERIALS AND METHOD
Score
Staining description Significance 3+
Strong complete membrane staining in more than 30% of tumor cell population Immuno positive
2+
Moderate membrane staining in more than 10% of tumor cell population Weakly or border-line positive
1+
Either weak or perceptible membrane staining in more than 10% of tumor cell population HER2 negative
Zero
Completely negative staining in less than 10% of tumor cell population HER2 negative
RESULTS
The age groups ranged from 23 to 78 years old with a mean age of 48 years old. Most of the patients were less than or equal to 50 years old with a percentage of (60.5%). There is a significant positive correlation between ER, PR and age (P value 0.02) and a significant negative correlation between ER, PR and grade of tumor (P value 0.01). Also a negative correlation between ER, PR and stage of tumor is found, however this association is statistically not significant (P value 0.1).There is No significant association between HER2 with age and grade; but a significant positive relationship between HER2 and stage of tumor is shown (P value 0.01) as shown in (Table-II) .
It has been found that there is an inverse correlation between ER and HER2 which is just statistically significant (p value 0.05) and majority of ER positive tumors were lacking HER2 (78.6%). Similarly the majority of PR +ve tumors (75.5%) were HER2 negative; however this association is not statistically significant (0.2) as shown in (Table-III) . According to the positivity and negativity of ER, PR and HER2, the majority of cases were of ER +ve/PR +ve/HER2 -ve (PPN) 30%, There is a significant positive correlation between ER, PR and age (P value 0.02) and a significant negative correlation between ER, PR and grade of tumor (P value 0.01). Also a negative correlation between ER, PR and stage of tumor is found, however this association is statistically not significant (P value 0.1).There is No significant association between HER2 with age and grade; but a significant positive relationship between HER2 and stage of tumor is shown (P value 0.01) as shown in (Table-II) .
It has been found that there is an inverse correlation between ER and HER2 which is just statistically significant (p value 0.05) and majority of ER positive tumors were lacking HER2 (78.6%). Similarly the majority of PR +ve tumors (75.5%) were HER2 negative; however this association is not statistically significant (0.2) as shown in (Table-III) . According to the positivity and negativity of ER, PR and HER2, the majority of cases were of ER +ve/PR +ve/HER2 -ve (PPN) 30%, followed by triple negative tumor ER -ve/PRve/HER2-ve) (NNN) 19.7% as shown in (Table-IV) . It has been showed that the majority of ER +ve/ PR +ve/HER2-ve tumors (PPN) frequently occur in older age group, lower grade and earlier stage. While triple negative tumors (NNN) mainly found in younger age patients, higher grade and later stage as shown in (Table-V) . 
DISCUSSION
Breast cancer is a disease with a tremendous heterogeneity in its behavior. Clinical and pathological variables of tumors such as histological grade, type, stage, age and hormonal status may help in predicting prognosis and need for adjuvant therapy. [14, 15] In this study, breast cancer is found to affect younger age women. This is corresponding to similar studies in other parts of Iraq, [16, 17] some Arabic countries, [14, 15, 18, [19] [20] [21] Iran [22] and third world countries. [23, 24, 25, 26] However in western countries the disease is more common in older age women. [27, 28] These finding could be due to environmental or genetic factors. It has been found that the majority of the patients (72%) presented with grade II and stage II cancer. These findings have been reported in other studies. [4, [15] [16] [17] [18] [19] [20] [29] [30] [31] This late presentation may reflect the poor health education of general population and ignorance regarding the significance of clinical breast examination, breast self examination, early medical consultation and screening programme. Also negligence, poverty and fear of mastectomy play an important role in delay presentation. The prevalence of ER & PR positivity was 55% and 49% respectively. The finding of ER expression is nearly similar to results of other studies done in Baghdad, [16] Jordon [14] Saudi Arabia [15] Tunis [18] Egypt, [19] which range from 53-65%. And differ from those reported in Lebanon [22] black women in US and Austrian women [32] Nigeria. [33] Variation in the percentage of ER expression among population could be attributed to factors related to tissue fixation and antigen preservation, because prolonged tissue fixation (more than 24 hours) can cause masking of the antigenic epitope and results in strong non-specific background staining.
[10] The percentage of HER2 overexpression was 30% which appear to be within higher limit of accepted rates of 20-30%. [9] This result is nearly similar to what reported in studies done in Jordon [14] Saudi Arabia [15] Tunis [18] and Egypt [19] But it differ from study done in Baghdad [16] and Iran [23] which show higher percentage of HER2 over-expression (46%) This variation in HER2 expression may reflect differences in the subjective evaluation of HER2 status. An inverse association has been found between HER2 over-expression and the presence of receptors for estrogen and progesterone; thus the higher the level of HER2 over-expression the lower the corresponding ER and PR positivity. These finding are in agreement with results in other worldwide studies. [14, 15, 17, 18, 26, 27] This has been explained by hormone-dependent down regulation of HER2 involving a complex molecular interaction. Estrogen and its receptor are required to suppress HER2, [15] this explained the HER2 over-expression in women with low or absent ER expression. But they differ from study in Iran [23] which shows no significant association between hormone receptors and HER2 status. A strong association has been found between patient age and ER, PR expression. Younger patients are more likely having breast cancer with negative hormone receptors than older women. These findings are similar to that found in other studies. [14, 16, 15, 18, 19] No significance association has been found between HER2 overexpression and age of the patients. These finding differ from the results of other studies which show a significant negative association between age and HER2 over-expression [16, 14, 18, 23] and also differ from results of study done in Saudi Arabia [15] which showed that HER2 overexpression was significantly higher among post menopausal women. But these results were similar to study done in Egypt [19] which also shows that there is no significant association between HER2 over-expression and age of the patient. These differences could be also due to the subjective nature of HER2 scoring system. A significant association has been found between tumor grade and ER, PR expressions; the lower the grade of tumors the higher the ER and PR positivity and vice versa. Therefore, there is a uniform loss of ER content as the tumor becomes more anaplastic indicating that hormone receptors status could represent one aspect of tumor cell differentiation, as the grade increase (cell differentiation decrease) and hormone expression decrease. These findings are similar to other studies. [14] [15] [16] 18, 19] In this study, it has been found that HER2 overexpression was positively correlated with tumor grade and 53% of grade III tumors were HER2 +ve, but this finding was not statistically significant. This result is similar to that reported in other studies. [14] [15] [16] [17] [18] which show no significant association between HER2 and grade of tumor. However, these results differ from other studies which show significant association between HER2 and histological grade. [14, 19] This difference could be due the small sample size. An inverse relationship has been found between hormone receptors ER & PR positivity and stage of tumor i.e. the percentage of ER+ve and PR+ve tumors decrease as the stage increase; but this association is not statistically significant, these findings were similar to other studies. [18, 23] This can be explained by the direct association between grade and stage of tumor.
However the small sample size may be responsible for the insignificant relationship between hormone receptors and tumor stage. There is a significant direct association between HER2 and stage of tumor. These findings are corresponding with results in other studies. [14] [15] [16] 18, 33, 34] But it differs from study done in Iran which shows no significant association between HER2 and stage of tumor. [23] In this study, it has been found that tumor with positive ER and PR and negative HER2 (PPN) formed the higher percentage among other types of breast cancer (30%) and is associated with older age women, lower grade and earlier stage (better prognosis), followed by tumor with triple negative receptors (NNN) 19.7% which commonly seen in younger age women, grade III and stage IIIA at presentation (worse prognosis). These finding are corresponding to the results of other studies. [15, 35] In conclusion, breast cancer in our locality is characterized by an early age occurrence. Most patients regardless to their age are presented with a moderately advanced grade and stage at time of diagnosis. About half of the patients had positive hormonal expression (ER or PR) and one third had HER2 over-expression. There is a negative correlation between HER2 overexpression and hormone receptors. ER+ve/PR+ve/HER2 -ve tumors are occurred frequently in older women and are associated with more favorable clinico-pathological parameters than that of TNBC (Triple Negative Breast Cancer).
